Answer
The Brown & Burk UK Ltd co-amoxiclav 500 mg/125 mg film-coated tablets product should be dosed cautiously in patients with hepatic impairment, with hepatic function monitored at regular intervals.
Sources for this answer
- Co-amoxiclav 500mg/125mg Film-coated TabletsBrown & Burk UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked